Page last updated: 2024-09-05

sb 203580 and Scleroderma, Systemic

sb 203580 has been researched along with Scleroderma, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gore, EA; McDermott, PJ; Sato, M; Shegogue, D; Smith, EA; Trojanowska, M	1

Other Studies

1 other study(ies) available for sb 203580 and Scleroderma, Systemic

Article	Year
Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. The Journal of investigative dermatology, 2002, Volume: 118, Issue:4 Topics: Adult; Cells, Cultured; Collagen; Collagen Type I; Dermis; Enzyme Inhibitors; Extracellular Matrix; Female; Fibroblasts; Gene Expression; Humans; Imidazoles; Male; Middle Aged; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; RNA, Messenger; Scleroderma, Systemic; Transforming Growth Factor beta	2002

Article

Year

Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts.

The Journal of investigative dermatology, 2002, Volume: 118, Issue:4

Topics: Adult; Cells, Cultured; Collagen; Collagen Type I; Dermis; Enzyme Inhibitors; Extracellular Matrix; Female; Fibroblasts; Gene Expression; Humans; Imidazoles; Male; Middle Aged; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; RNA, Messenger; Scleroderma, Systemic; Transforming Growth Factor beta

2002